531-14-6
531-14-6
Chemical Structure
Coproporphyrin I
- CAS No.: 531-14-6
- Formula:C36H38N4O8
- Molecular Weight:654.71
IUPAC Name: 3,3',3'',3'''-(3,8,13,18-tetramethylporphyrin-2,7,12,17-tetrayl)tetrapropionic acid
InChIKey: VORBHEGMEBOMMB-JRHDEHKPSA-N
SMILES: O=C(O)CCC1=C2/C=C3C(C)=C(CCC(O)=O)C(/C=C(N/4)/C(C)=C(CCC(O)=O)C4=C\C5=N/C(C(CCC(O)=O)=C5C)=C\C(N2)=C1C)=N/3
Biological Activity: Coproporphyrin I is an endogenous metabolite present in Urine and Blood that can be used for the research of Liver Disease and Porphyria[1][2][3][4].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Coproporphyrin I | 99.68% | Coproporphyrin I is an endogenous metabolite present in Urine and Blood that can be used for the research of Liver Disease and Porphyria. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Coproporphyrin I-15N4 | 99.19% | Coproporphyrin I-15N4 is a 15N-labeled Coproporphyrin I (HY-113318). Coproporphyrin I is an endogenous metabolite present in urine and blood that can be used for the research of liver disease and porphyria. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Lee N, et al. Endogenous toxic metabolites and implications in cancer therapy. Oncogene. 2020 Aug;39(35):5709-5720. [Content Brief]
- [2]. Zuijderhoudt FM, et al. On accuracy and precision of a HPLC method for measurement of urine porphyrin concentrations. Clin Chem Lab Med. 2000 Mar;38(3):227-30. [Content Brief]
- [3]. Hindmarsh JT, et al. Biochemical differentiation of the porphyrias. Clin Biochem. 1999 Nov;32(8):609-19. [Content Brief]
- [4]. MAGNUS IA, et al. Erythropoietic protoporphyria. A new porphyria syndrome with solar urticaria due to protoporphyrinaemia. Lancet. 1961 Aug 26;2(7200):448-51. [Content Brief]
